Correlation Between Revolution Medicines and Catalent
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Catalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Catalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Catalent, you can compare the effects of market volatilities on Revolution Medicines and Catalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Catalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Catalent.
Diversification Opportunities for Revolution Medicines and Catalent
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Revolution and Catalent is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Catalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalent and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Catalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalent has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Catalent go up and down completely randomly.
Pair Corralation between Revolution Medicines and Catalent
Given the investment horizon of 90 days Revolution Medicines is expected to generate 1.24 times more return on investment than Catalent. However, Revolution Medicines is 1.24 times more volatile than Catalent. It trades about 0.07 of its potential returns per unit of risk. Catalent is currently generating about 0.04 per unit of risk. If you would invest 2,378 in Revolution Medicines on August 30, 2024 and sell it today you would earn a total of 3,480 from holding Revolution Medicines or generate 146.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revolution Medicines vs. Catalent
Performance |
| Timeline |
| Revolution Medicines |
| Catalent |
Revolution Medicines and Catalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revolution Medicines and Catalent
The main advantage of trading using opposite Revolution Medicines and Catalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Catalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will offset losses from the drop in Catalent's long position.| Revolution Medicines vs. Ikena Oncology | Revolution Medicines vs. Eliem Therapeutics | Revolution Medicines vs. HCW Biologics | Revolution Medicines vs. RenovoRx |
| Catalent vs. Emergent Biosolutions | Catalent vs. Bausch Health Companies | Catalent vs. Neurocrine Biosciences | Catalent vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |